Cullinan Therapeutics, Inc. CGEM Earnings yield
Earnings yield at other companies
Other financials
Where this comes from
Calculated from Cullinan Therapeutics, Inc.’s reported figures.
Based on trailing twelve months.
The official record: Cullinan Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cullinan Therapeutics, Inc.'s earnings yield.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cullinan Therapeutics, Inc.'s earnings yield?
- Cullinan Therapeutics, Inc. (CGEM) reported earnings yield of -25.7% in Q1 2026.
- How has Cullinan Therapeutics, Inc.'s earnings yield changed year-over-year?
- Cullinan Therapeutics, Inc.'s earnings yield increased by 36.3% year-over-year, from -40.4% to -25.7%.
- What is the long-term trend for Cullinan Therapeutics, Inc.'s earnings yield?
- Over 3 years (2021 to 2025), Cullinan Therapeutics, Inc.'s earnings yield has grown at a 55.5% compound annual growth rate (CAGR), from -9.6% to -36%.
- What does earnings yield mean?
- Trailing-twelve-month net income divided by market capitalization at the quarter end — the inverse of the P/E ratio, expressed as a percentage.